CompletedNot applicableNCT01053156

Trial of Minocycline to Treat Children With Fragile X Syndrome

Studying Fragile X syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of California, Davis
Principal Investigator
Randi J Hagerman, MD
M.I.N.D. Institute at University of California at Davis, Sacramento CA
Intervention
minocycline hydrochloride(drug)
Enrollment
66 enrolled
Eligibility
16 years · All sexes
Timeline
20102011

Study locations (1)

Collaborators

The National Fragile X Foundation

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01053156 on ClinicalTrials.gov

Other trials for Fragile X syndrome

Additional recruiting or active studies for the same condition.

See all trials for Fragile X syndrome

← Back to all trials